Nanomedicine Research Center,
Department of Neurosurgery,
Nanomedicine Research Center, Department of Neurosurgery
Julia Y. Ljubimova has not added Biography.
If you are Julia Y. Ljubimova and would like to personalize this page please email our Author Liaison for assistance.
Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro.
Molecular cancer therapeutics Oct, 2003 | Pubmed ID: 14578463
Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
Cancer Aug, 2004 | Pubmed ID: 15274074
Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases.
Breast cancer research : BCR , 2005 | Pubmed ID: 15987446
Changes in laminin isoforms associated with brain tumor invasion and angiogenesis.
Frontiers in bioscience : a journal and virtual library , 2006 | Pubmed ID: 16146715
Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.
Investigative ophthalmology & visual science Oct, 2005 | Pubmed ID: 16186340
Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.
Bioconjugate chemistry Mar-Apr, 2006 | Pubmed ID: 16536461
Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.
Angiogenesis , 2006 | Pubmed ID: 17109197
Nanoconjugate based on polymalic acid for tumor targeting.
Chemico-biological interactions Jan, 2008 | Pubmed ID: 17376417
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
Journal of controlled release : official journal of the Controlled Release Society Oct, 2007 | Pubmed ID: 17630012
Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.
Nanomedicine (London, England) Apr, 2008 | Pubmed ID: 18373429
Adenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes.
Brain research bulletin Feb, 2010 | Pubmed ID: 19828126
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
NeuroImage Jan, 2011 | Pubmed ID: 20149882
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).
Pharmaceutical research Nov, 2010 | Pubmed ID: 20387095
Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models.
PloS one , 2010 | Pubmed ID: 20419092
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
Proceedings of the National Academy of Sciences of the United States of America Oct, 2010 | Pubmed ID: 20921419
Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
Cancer research Feb, 2011 | Pubmed ID: 21303974
The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.
Biomaterials Aug, 2011 | Pubmed ID: 21514661
New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery.
International journal of pharmaceutics Feb, 2012 | Pubmed ID: 21550387
Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs.
Macromolecular bioscience Oct, 2011 | Pubmed ID: 21793213
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
Biochimica et biophysica acta Mar, 2012 | Pubmed ID: 21851850
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.
PloS one , 2012 | Pubmed ID: 22355336
Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery.
Journal of nanotechnology , 2010 | Pubmed ID: 23024655
Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers.
Biomaterials Jan, 2013 | Pubmed ID: 23063368
Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid).
International journal of molecular sciences , 2012 | Pubmed ID: 23109877
Biocompatible nanopolymers: the next generation of breast cancer treatment?
Nanomedicine (London, England) Oct, 2012 | Pubmed ID: 23148535
Gene expression changes in rat brain after short and long exposures to particulate matter in Los Angeles basin air: Comparison with human brain tumors.
Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie Nov, 2013 | Pubmed ID: 23688656
Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer.
Journal of controlled release : official journal of the Controlled Release Society Nov, 2013 | Pubmed ID: 23770212
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
Journal of drug targeting Dec, 2013 | Pubmed ID: 24032759
Nanomedicine therapeutic approaches to overcome cancer drug resistance.
Advanced drug delivery reviews Nov, 2013 | Pubmed ID: 24120656
Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors.
Neurosurgical focus Feb, 2014 | Pubmed ID: 24484247
Multilayer films assembled from naturally-derived materials for controlled protein release.
Biomacromolecules Jun, 2014 | Pubmed ID: 24825478
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved